These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6209348)

  • 1. Developmentally regulated expression of the interferon system during Syrian hamster embryogenesis.
    Greene JJ; Dyer RH; Yang LC; Ts'o PO
    J Interferon Res; 1984; 4(4):517-27. PubMed ID: 6209348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proliferation-related constraint on endogenous and interferon-induced 2-5A synthetase activity in normal and neoplastic Syrian hamster cells.
    Hassel BA; Ts'o PO
    Mol Carcinog; 1992; 5(1):41-51. PubMed ID: 1371923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial purification and characterization of Syrian hamster interferon.
    Bollin E; Sulkowski E
    J Gen Virol; 1981 Feb; 52(Pt 2):227-33. PubMed ID: 6169782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro development of bone-marrow-derived macrophages. Influence of mouse genotype on response to colony-stimulating factors and autocrine interferon induction.
    Kruse A; Kirchner H; Zawatzky R; Domke-Opitz I
    Scand J Immunol; 1989 Dec; 30(6):731-40. PubMed ID: 2481339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracrine activities of porcine trophoblastic interferons.
    D'Andrea S; Chousterman S; Flechon JE; La Bonnardière C
    J Reprod Fertil; 1994 Sep; 102(1):185-94. PubMed ID: 7799312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of interferon in human diploid cell cultures.
    Zielińska-Jenczylik J; Rzucidlo Z; Sypula A; Blach-Olszewska Z; Kidankiewicz T
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):769-75. PubMed ID: 187142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2',5'-adenylate synthetase.
    Mestan J; Brockhaus M; Kirchner H; Jacobsen H
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():3113-20. PubMed ID: 2462015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction by vasoactive intestinal peptide of interferon alpha/beta synthesis in glial cells but not in neurons.
    Chelbi-Alix MK; Brouard A; Boissard C; Pelaprat D; Rostene W; Thang MN
    J Cell Physiol; 1994 Jan; 158(1):47-54. PubMed ID: 7505279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of MuIFN-alpha/beta and MuIFN-gamma-induced antiviral states: differential effects with different challenge viruses and lack of correlation with 2'5' oligoadenylate synthetase levels.
    Ramamurthy V; Fleischmann WR
    J Biol Regul Homeost Agents; 1988; 2(1):7-14. PubMed ID: 2845725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meliacine, an antiviral compound from Melia azedarach L., inhibits interferon production.
    Andrei GM; Coulombie FC; Courreges MC; de Torres RA; Coto CE
    J Interferon Res; 1990 Oct; 10(5):469-75. PubMed ID: 1703195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon inducibility and sensitivity of human teratocarcinoma-derived cell lines.
    Ogunkolade W; Canivet M; Pochart F; Fourcade A; Chousterman S; Hovanessian A; Peries J
    J Interferon Res; 1987 Jun; 7(3):245-54. PubMed ID: 2440957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP-mediated inhibition of vesicular stomatitis virus and herpes simplex virus replication in mouse macrophage-like cells.
    Borghi P; Di Marzio P; Varano B; Conti L; Belardelli F; Gessani S
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2949-54. PubMed ID: 1279103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on interferon-sensitive cells derived from the interferon-resistant NIH 3T3 clone 1 line.
    Mittnacht S; Jacobsen H
    Prog Clin Biol Res; 1985; 202():237-45. PubMed ID: 2421304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of macrophage growth and antiviral activity by interferon-gamma.
    Goldberg M; Belkowski LS; Bloom BR
    J Cell Biol; 1989 Sep; 109(3):1331-40. PubMed ID: 2549078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon.
    Preble OT; Rothko K; Klippel JH; Friedman RM; Johnston MI
    J Exp Med; 1983 Jun; 157(6):2140-6. PubMed ID: 6189954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of interferon on the production of HBsAg and induction of an antiviral state in human hepatoma cell line PLC/PRF/5.
    Nakajima Y; Kuwata T; Tomita Y; Okuda K
    Microbiol Immunol; 1982; 26(8):705-12. PubMed ID: 6294485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of (2'-5') oligo-adenylate synthetase and interferon blood-levels in mice early after viral infection.
    Schattner A; Merlin G; Shapira A; Revel M; Wallach D
    J Interferon Res; 1982; 2(2):285-9. PubMed ID: 6181178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-Inducible Oligoadenylate Synthetase-Like Protein Acts as an Antiviral Effector against Classical Swine Fever Virus via the MDA5-Mediated Type I Interferon-Signaling Pathway.
    Li LF; Yu J; Zhang Y; Yang Q; Li Y; Zhang L; Wang J; Li S; Luo Y; Sun Y; Qiu HJ
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon production associated with the ageing of primary chick embryo cells is not caused by priming.
    Kohase M; Saito S; Iizuka E; Matsumura H; Kohno S
    J Gen Virol; 1983 Sep; 64 (Pt 9)():2017-20. PubMed ID: 6193247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bioassay for serum interferon based on induction of 2'5'-oligoadenylate synthetase activity.
    Uno K; Sato T; Takada Y; Fujioka K; Suginoshita Y; Kakimi K; Moriyasu F; Kishida T
    J Interferon Cytokine Res; 1998 Dec; 18(12):1011-8. PubMed ID: 9877443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.